Skip to main content
VCbacked
Log inGet Started

Kanaph Therapeutics

Yongsan, South Korea

Kanaph Therapeutics is a leading biotech in oncology, auto-immune, and eye diseases with large molecules and small molecules.

$17.8M raised
Dec 2023
Series C
BiotechnologyLife ScienceOncologyPharmaceutical

Top Investors

InterVest Co.Premier PartnersLOTTE BiologicsAju IB InvestmentDayli Partners

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Kanaph Therapeutics

How much funding has Kanaph Therapeutics raised?
Kanaph Therapeutics has raised $17.8M in total funding. The most recent round was Series C. The last funding was announced in December 2023.
Who are Kanaph Therapeutics's investors?
Kanaph Therapeutics's investors include InterVest Co., Premier Partners, LOTTE Biologics, Aju IB Investment, Dayli Partners.
Where is Kanaph Therapeutics headquartered?
Kanaph Therapeutics is headquartered in Yongsan, South Korea.
What does Kanaph Therapeutics do?
Kanaph Therapeutics is a leading biotech in oncology, auto-immune, and eye diseases with large molecules and small molecules.
What stage is Kanaph Therapeutics at?
Kanaph Therapeutics is at the Series C stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Kanaph Therapeutics — Funding & Investors." VCBacked, December 27, 2023, https://www.vcbacked.co/company/kanaph-therapeutics. Accessed June 10, 2026.
APA
VCBacked. (2023). Kanaph Therapeutics — Funding & Investors. Retrieved June 10, 2026, from https://www.vcbacked.co/company/kanaph-therapeutics
Wikipedia (cite web)
{{cite web |title=Kanaph Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/kanaph-therapeutics |website=VCBacked |access-date=June 10, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong